Your browser doesn't support javascript.
loading
A phase 2 study of sorafenib combined with conventional therapies in refractory central nervous system leukemia.
Chen, Xiaoxia; Huang, Junwei; Xu, Na; Fan, Zhiping; Nie, Danian; Huang, Fen; Sun, Qixin; Zhang, Xinyou; Liang, Xinquan; Shi, Pengcheng; Wang, Zhixiang; Liu, Hui; Xu, Jun; Dai, Min; Yu, Guopan; Zhang, Yu; Sun, Jing; Liu, Qifa; Xuan, Li.
Affiliation
  • Chen X; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Huang J; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Xu N; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Fan Z; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Nie D; Department of Hematology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Huang F; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Sun Q; Department of Geriatrics, Hematology and Oncology Ward, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Zhang X; Department of Hematology, Shenzhen People's Hospital, Shenzhen, China.
  • Liang X; Department of Hematology, First People's Hospital of Chenzhou, Chenzhou, China.
  • Shi P; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Wang Z; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Liu H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Xu J; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Dai M; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Yu G; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang Y; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Sun J; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Liu Q; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Xuan L; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Cancer ; 128(11): 2138-2147, 2022 06 01.
Article in En | MEDLINE | ID: mdl-35315510
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Leukemia / Central Nervous System Neoplasms / Graft vs Host Disease Type of study: Observational_studies Language: En Journal: Cancer Year: 2022 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Leukemia / Central Nervous System Neoplasms / Graft vs Host Disease Type of study: Observational_studies Language: En Journal: Cancer Year: 2022 Type: Article Affiliation country: China